Literature DB >> 21445971

Increased frequency of 20q gain and copy-neutral loss of heterozygosity in mismatch repair proficient familial colorectal carcinomas.

A Middeldorp1, R van Eijk, J Oosting, G I Forte, M van Puijenbroek, M van Nieuwenhuizen, W E Corver, D Ruano, T Caldes, J Wijnen, H Morreau, T van Wezel.   

Abstract

Many hereditary nonpolyposis colorectal cancers (CRCs) cannot be explained by Lynch syndrome. Other high penetrance genetic risk factors are likely to play a role in these mismatch repair (MMR)-proficient CRC families. Because genomic profiles of CRC tend to vary with CRC susceptibility syndromes, our aim is to analyze the genomic profile of MMR-proficient familial CRC to obtain insight into the biological basis of MMR-proficient familial CRC. We studied 30 MMR-proficient familial colorectal carcinomas, from 15 families, for genomic aberrations, including gains, physical losses, and copy-neutral loss of heterozygosity LOH (cnLOH) using SNP array comparative genomic hybridization. In addition, we performed somatic mutation analysis for KRAS, BRAF, PIK3CA and GNAS. The frequency of 20q gain (77%) is remarkably increased when compared with sporadic CRC, suggesting that 20q gain is involved in tumor progression of familial CRC. There is also a significant increase in the frequency of cnLOH and, as a consequence, a reduced frequency of physical loss compared with sporadic CRC. The most frequent aberrations observed included gains of 7p, 7q, 8q, 13q, 20p and 20q as well as physical losses of 17p, 18p and 18q. Most of these changes are also observed in sporadic CRC. Mutations in KRAS were identified in 37% of the MMR-proficient CRCs, and mutations in BRAF were identified in 16%. No mutations were identified in PIK3CA or chromosome 20 candidate gene GNAS. We show that the patterns of chromosomal instability of MMR-proficient familial CRC are clearly distinct from those from sporadic CRC. Both the increased gain on chromosome 20 and the increased levels of cnLOH suggest the presence of yet undiscovered germline defects that can, in part, underlie the cancer risk in these families.
Copyright © 2011 UICC.

Entities:  

Mesh:

Year:  2011        PMID: 21445971     DOI: 10.1002/ijc.26093

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  14 in total

Review 1.  Specific changes in the expression of imprinted genes in prostate cancer--implications for cancer progression and epigenetic regulation.

Authors:  Teodora Ribarska; Klaus-Marius Bastian; Annemarie Koch; Wolfgang A Schulz
Journal:  Asian J Androl       Date:  2012-02-27       Impact factor: 3.285

2.  Rare germline alterations in cancer-related genes associated with the risk of multiple primary tumor development.

Authors:  Rolando A R Villacis; Tatiane R Basso; Luisa M Canto; Maísa Pinheiro; Karina M Santiago; Juliana Giacomazzi; Cláudia A A de Paula; Dirce M Carraro; Patrícia Ashton-Prolla; Maria I Achatz; Silvia R Rogatto
Journal:  J Mol Med (Berl)       Date:  2017-01-16       Impact factor: 4.599

3.  DNA copy number profiling in microsatellite-stable and microsatellite-unstable hereditary non-polyposis colorectal cancers by targeted CNV array.

Authors:  Weixiang Chen; Jun Ding; Long Jiang; Zebing Liu; Xiaoyan Zhou; Daren Shi
Journal:  Funct Integr Genomics       Date:  2016-11-28       Impact factor: 3.410

Review 4.  Genetic predisposition to colorectal cancer: where we stand and future perspectives.

Authors:  Laura Valle
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

5.  Molecular patterns in the evolution of serrated lesion of the colorectum.

Authors:  Timo Gaiser; Sandra Meinhardt; Daniela Hirsch; Jonathan Keith Killian; Jochen Gaedcke; Peter Jo; Immaculada Ponsa; Rosa Miró; Josef Rüschoff; Gerhard Seitz; Yue Hu; Jordi Camps; Thomas Ried
Journal:  Int J Cancer       Date:  2012-10-17       Impact factor: 7.396

Review 6.  Familial colorectal cancer type X: genetic profiles and phenotypic features.

Authors:  Mev Dominguez-Valentin; Christina Therkildsen; Sabrina Da Silva; Mef Nilbert
Journal:  Mod Pathol       Date:  2014-04-18       Impact factor: 7.842

7.  A genome-wide study of cytogenetic changes in colorectal cancer using SNP microarrays: opportunities for future personalized treatment.

Authors:  Farzana Jasmine; Ronald Rahaman; Charlotte Dodsworth; Shantanu Roy; Rupash Paul; Maruf Raza; Rachelle Paul-Brutus; Mohammed Kamal; Habibul Ahsan; Muhammad G Kibriya
Journal:  PLoS One       Date:  2012-02-20       Impact factor: 3.240

8.  Distinct gene expression signatures in lynch syndrome and familial colorectal cancer type x.

Authors:  Mev Dominguez-Valentin; Christina Therkildsen; Srinivas Veerla; Mats Jönsson; Inge Bernstein; Ake Borg; Mef Nilbert
Journal:  PLoS One       Date:  2013-08-12       Impact factor: 3.240

Review 9.  Molecular pathogenesis of B-cell posttransplant lymphoproliferative disorder: what do we know so far?

Authors:  J Morscio; D Dierickx; T Tousseyn
Journal:  Clin Dev Immunol       Date:  2013-04-14

10.  Integral analysis of p53 and its value as prognostic factor in sporadic colon cancer.

Authors:  Arantza Fariña Sarasqueta; Giusi Forte; Wim E Corver; Noel F de Miranda; Dina Ruano; Ronald van Eijk; Jan Oosting; Rob A E M Tollenaar; Tom van Wezel; Hans Morreau
Journal:  BMC Cancer       Date:  2013-06-05       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.